GlaxoSmithKline Czech Republic - Net Debt

Created with Highcharts 6.0.4CZK mil200320042005200620072008200920102011201220132014201520162017-600-400-2000200400

GlaxoSmithKline CR`s Net Debt reached -209 CZK mil in 2017. This is 40.3 % less than in the previous year.

$1.99

Buy Net Debt data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
CompanyUnit
Amgen Czech Republic CZK mil
Bayer Czech Republic CZK mil
GlaxoSmithKline Czech Republic CZK mil
Merck Czech Republic CZK mil
Novartis Czech Republic CZK mil
Pfizer Czech Republic CZK mil
Roche Czech Republic CZK mil
Sanofi-Aventis Czech Republic CZK mil
Servier Czech Republic CZK mil
Walmark CZK mil
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
... ... ... ... ...             0 0 -0.222 38.6 70.7    
... ... ...                 -50.0 -11.0 19.0 21.5 150    
... ... ...                 136 240 319 -0.193 -515    
... ...                   126 116 138 18.9 -2.47    
                      198 48.6 -4.57 93.2 -1.97    
... ...                   684 -87.9 -24.3 -284 -4.12    
... ... ...                 -0.376 151 285 541 660   ...
... ... ... ...               1,165 1,333 877 471 404    
... ... ... ... ... ... ... ... ... ... ... ... -29.6 -41.9 -36.1 -20.0    
... ... ...                 163 717 553 487 1,297